Form 4: Elanco Animal Health Executive James M. Meer Reports Stock Grant and Disposal

James M. Meer, Chief Accounting Officer of Elanco Animal Health, reports the acquisition of restricted stock units and disposal of common stock.

Summary

• On March 3, 2025, James M. Meer, Chief Accounting Officer of Elanco Animal Health Inc., reported a transaction involving the company's stock.
• Meer acquired 12,158 shares of common stock through a grant of restricted stock units.
• These restricted stock units vest in three equal installments on March 3, 2026, March 3, 2027, and March 3, 2028.
• Meer also disposed of 59,264 shares of common stock.
• Following these transactions, Meer beneficially owns 59,264 shares of Elanco Animal Health Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions by a company executive.

Positives

• The grant of restricted stock units aligns the executive's interests with the long-term performance of the company.

Negatives

• The disposal of 59,264 shares could be interpreted negatively by investors, although the reason for disposal is not specified.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may be interested in the executive's stock transactions as an indicator of confidence in the company's future prospects.

Key Dates